Alphatec Holdings (ATEC) | Financial Analysis & Statements
Alphatec Holdings Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
212.9M
Gross Profit
149.5M
70.21%
Operating Income
-5.4M
-2.52%
Net Income
-21.7M
-10.20%
EPS (Diluted)
$-0.14
Balance Sheet Metrics
Total Assets
791.2M
Total Liabilities
778.8M
Shareholders Equity
12.4M
Debt to Equity
62.67
Cash Flow Metrics
Operating Cash Flow
24.2M
Free Cash Flow
5.7M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Alphatec Holdings Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 764.2M | 611.6M | 482.3M | 350.9M | 243.2M |
| Cost of Goods Sold | 232.3M | 187.3M | 172.1M | 117.8M | 85.4M |
| Gross Profit | 531.9M | 424.3M | 310.2M | 233.1M | 157.8M |
| Gross Margin % | 69.6% | 69.4% | 64.3% | 66.4% | 64.9% |
| Operating Expenses | |||||
| Research & Development | 76.3M | 80.7M | 70.1M | 44.0M | 32.0M |
| Selling, General & Administrative | 498.5M | 450.2M | 374.1M | 300.0M | 229.3M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 574.8M | 530.9M | 444.2M | 344.0M | 261.3M |
| Operating Income | -58.0M | -122.9M | -148.3M | -121.1M | -108.9M |
| Operating Margin % | -7.6% | -20.1% | -30.7% | -34.5% | -44.8% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 45.9M | 24.9M | 16.6M | 5.5M | 7.1M |
| Other Non-Operating Income | -39.5M | -14.3M | -22.0M | -25.4M | -28.2M |
| Pre-tax Income | -143.4M | -162.1M | -186.9M | -152.0M | -144.2M |
| Income Tax | -45.0K | 50.0K | -277.0K | -716.0K | -1.1M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -143.4M | -162.1M | -186.6M | -151.3M | -143.0M |
| Net Margin % | -18.8% | -26.5% | -38.7% | -43.1% | -58.8% |
| Key Metrics | |||||
| EBITDA | 26.2M | -40.6M | -85.5M | -76.7M | -80.3M |
| EPS (Basic) | $-0.96 | $-1.13 | $-1.54 | $-1.47 | $-1.50 |
| EPS (Diluted) | $-0.96 | $-1.13 | $-1.54 | $-1.47 | $-1.50 |
| Basic Shares Outstanding | 150064000 | 142946000 | 121242000 | 103373000 | 96197000 |
| Diluted Shares Outstanding | 150064000 | 142946000 | 121242000 | 103373000 | 96197000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Alphatec Holdings Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 160.8M | 138.8M | 221.0M | 84.7M | 187.2M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 97.3M | 83.0M | 72.6M | 60.1M | 41.9M |
| Inventory | 169.4M | 175.3M | 136.8M | 101.5M | 91.7M |
| Other Current Assets | 23.3M | 20.3M | 20.7M | 9.4M | 10.3M |
| Total Current Assets | 450.9M | 417.4M | 451.1M | 255.6M | 331.2M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 342.7M | 318.3M | 250.8M | 187.3M | 155.7M |
| Goodwill | 243.9M | 235.5M | 248.5M | 177.5M | 164.7M |
| Intangible Assets | 93.5M | 93.5M | 102.5M | 82.8M | 85.3M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 5.1M | 2.7M | 2.4M | 4.9M | 3.2M |
| Total Non-Current Assets | 340.3M | 358.3M | 354.1M | 265.3M | 240.9M |
| Total Assets | 791.2M | 775.7M | 805.2M | 521.0M | 572.1M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 40.9M | 53.0M | 49.0M | 34.7M | 25.7M |
| Short-term Debt | 70.8M | 8.1M | 7.0M | 19.8M | 4.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 5.9M | 4.3M | 8.0M | 5.6M | 4.3M |
| Total Current Liabilities | 219.2M | 153.0M | 157.6M | 138.9M | 101.1M |
| Non-Current Liabilities | |||||
| Long-term Debt | 525.3M | 601.8M | 534.7M | 376.1M | 350.9M |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 3.1M | 3.2M | 2.8M | 7.5M | 12.6M |
| Total Non-Current Liabilities | 559.6M | 636.9M | 569.5M | 416.8M | 391.5M |
| Total Liabilities | 778.8M | 789.9M | 727.1M | 555.6M | 492.6M |
| Equity | |||||
| Common Stock | 14.0K | 14.0K | 14.0K | 11.0K | 10.0K |
| Retained Earnings | -1.4B | -1.3B | -1.1B | -932.3M | -782.3M |
| Treasury Stock | 25.1M | 25.1M | 25.1M | 25.1M | 25.1M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 12.4M | -14.2M | 78.1M | -34.7M | 79.4M |
| Key Metrics | |||||
| Total Debt | 596.1M | 609.9M | 541.7M | 395.9M | 355.4M |
| Working Capital | 231.7M | 264.4M | 293.5M | 116.8M | 230.1M |
Balance Sheet Composition
Alphatec Holdings Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -143.4M | -162.1M | -186.6M | -151.3M | -143.0M |
| Depreciation & Amortization | 82.6M | 83.3M | 59.7M | 43.9M | 30.2M |
| Stock-Based Compensation | 73.7M | 73.3M | 81.2M | 40.6M | 36.4M |
| Working Capital Changes | -45.6M | -65.4M | -60.1M | -38.0M | -34.3M |
| Operating Cash Flow | -1.8M | -61.3M | -101.7M | -101.6M | -106.2M |
| Investing Activities | |||||
| Capital Expenditures | -42.5M | -83.2M | -80.5M | -49.5M | -68.5M |
| Acquisitions | 0 | 0 | -55.0M | 0 | -83.2M |
| Investment Purchases | -3.0M | - | 0 | 0 | -6.0M |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -46.2M | -83.2M | -135.5M | -49.5M | -157.8M |
| Financing Activities | |||||
| Share Repurchases | - | - | -1.1M | -3.0M | -31.0M |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 407.0M | 223.0M | 148.5M | 0 | 316.2M |
| Debt Repayment | -332.2M | -164.2M | -132.8M | -27.5M | -45.0M |
| Financing Cash Flow | 29.5M | 56.8M | 356.9M | 31.2M | 312.0M |
| Free Cash Flow | -4.4M | -137.8M | -165.5M | -133.4M | -141.9M |
| Net Change in Cash | -18.5M | -87.7M | 119.7M | -119.8M | 48.0M |
Cash Flow Trend
Alphatec Holdings Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-10.64
Forward P/E
18.23
Price to Book
126.27
Price to Sales
2.08
PEG Ratio
0.27
Profitability Ratios
Profit Margin
-18.76%
Operating Margin
-2.52%
Return on Equity
-630.66%
Return on Assets
-4.62%
Financial Health
Current Ratio
2.06
Debt to Equity
1,654.48
Beta
1.12
Per Share Data
EPS (TTM)
$-0.96
Book Value per Share
$0.08
Revenue per Share
$5.09
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ATEC | 1.5B | -10.64 | 126.27 | -630.66% | -18.76% | 1,654.48 |
| Abbott Laboratories | 160.7B | 25.97 | 3.09 | 12.36% | 13.90% | 26.79 |
| Stryker | 126.3B | 39.21 | 5.62 | 15.08% | 12.92% | 72.97 |
| Axogen | 1.9B | -110.18 | 13.15 | -13.49% | -6.97% | 55.50 |
| Establishment Labs | 1.9B | -37.89 | 79.68 | -133.25% | -24.19% | 1,123.15 |
| Artivion | 1.8B | 179.71 | 4.03 | 2.70% | 2.21% | 57.67 |
Financial data is updated regularly. All figures are in the company's reporting currency.






